Get started
mitchdevan

STML

Long
mitchdevan  
NASDAQ:STML   None
0
0
STML Biotech
• Stem cell therapies
• $7.00 per share in cash
• $250 million in market cap, similar companies are over $800
• $30.00 - $40.00 Upside
• $14.00 Downside
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.